why choose us

First received: December 26, 2022

Clinical Trial: Expanded Access to RBS2418

Condition: Expanded Access

Study Type: Expanded Access


Official Title: Expanded Access to RBS2418 for an Individual Patient With Pancreatic Cancer

Brief Summary: This is an expanded access treatment protocol designed to provide access of RBS2418 to a single patient with pancreatic cancer.

Read more